SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigel Pharmaceuticals is currently trending as investors focus on the anticipated mid-year commercial launch of Veppanu, the first FDA-approved PROTAC therapy, which the community views as a potential blockbuster asset. Despite strong fundamentals and profitability, the stock is seeing high volatility and significant short interest, leading to intense debate among retail investors about the potential for a short squeeze or strategic acquisition.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is trending as the market reacts to shifting geopolitical tensions in the Strait of Hormuz, with investors closely watching for the upcoming Valaris acquisition and potential earnings catalysts. The community is actively debating the stock's long-term potential as a beneficiary of offshore drilling demand versus short-term price volatility fueled by ongoing energy sector speculation.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is seeing renewed momentum driven by strong enthusiasm for its AI-powered 'Vector' advertising platform and anticipation surrounding the company's path toward GAAP profitability. The community is actively debating the stock's turnaround potential, with many investors closely monitoring analyst upgrades, potential acquisition rumors, and comparisons to peers like AppLovin.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Nano Nuclear Energy is gaining significant traction as investors bet on the company's progress toward commercializing portable microreactors, specifically following a strategic partnership with Supermicro to power AI data centers. The community is actively debating the stock's speculative growth potential against its lack of current revenue, with many traders focusing on the company's NRC licensing progress and its recent acquisition of logistics assets to verticalize its supply chain.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnival Corp is trending as investors weigh falling crude oil prices and ongoing Middle East geopolitical developments against concerns over high debt levels and interest rate environments. Community discussion remains highly active, with traders closely monitoring the potential for a peace deal, upcoming earnings, and the company's recent reinstatement of dividends and share buybacks.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is facing significant bearish sentiment as it trades near multi-year lows, with investors debating whether the current price represents a rare accumulation opportunity or a value trap. While the community remains deeply divided between those highlighting strong institutional utility and those frustrated by the coin's weak price action, the broader conversation is dominated by concerns over market manipulation and the need for a sustained recovery to restore confidence.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is gaining momentum as investors react to encouraging subcutaneous BRIUMVI data for myasthenia gravis, fueling optimism about expanding the drug's addressable market beyond multiple sclerosis. The community is actively debating the company's valuation, with many long-term shareholders anticipating a potential buyout and highlighting the asset as a strategic fit for larger pharmaceutical companies looking to capture significant market share.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors gear up for the upcoming quarterly earnings release and critical interim Phase 1 clinical data for its lead internal candidate, ABCL635. Community discussions are centered on strong institutional accumulation from major biotech-focused funds, while debate continues regarding the company's long-term platform potential versus its historical share price performance.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance continues to draw intense investor scrutiny as the market weighs the pending $110 billion merger with Warner Bros. Discovery against ongoing regulatory hurdles and recent antitrust lawsuits from several U.S. states. While shareholders express frustration over stagnant price action and the dilution associated with the deal, the community remains actively divided between those betting on long-term synergies and those deeply skeptical of management's ability to navigate current regulatory and debt headwinds.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is trending as investors weigh the company's potential role in high-speed AI data center infrastructure against the reality of pre-revenue operations and extended production timelines. Community discourse is heavily polarized, with supporters pointing to strategic partnerships and foundry collaborations as validation of the technology, while critics are sounding alarms over the valuation relative to current revenue and the long wait for high-volume manufacturing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

Akouos Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

AKUSAkouos Inc

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest AKUS News